4736 Stock Overview
TaiDoc Technology Corporation manufactures and markets medical devices worldwide.
TaiDoc Technology Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$161.00|
|52 Week High||NT$310.00|
|52 Week Low||NT$154.50|
|1 Month Change||-26.32%|
|3 Month Change||-17.44%|
|1 Year Change||-4.45%|
|3 Year Change||20.60%|
|5 Year Change||85.06%|
|Change since IPO||135.62%|
Recent News & Updates
|4736||TW Medical Equipment||TW Market|
Return vs Industry: 4736 exceeded the TW Medical Equipment industry which returned -8.1% over the past year.
Return vs Market: 4736 exceeded the TW Market which returned -18.5% over the past year.
|4736 Average Weekly Movement||6.0%|
|Medical Equipment Industry Average Movement||5.4%|
|Market Average Movement||5.1%|
|10% most volatile stocks in TW Market||8.3%|
|10% least volatile stocks in TW Market||2.4%|
Stable Share Price: 4736 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 4736's weekly volatility (6%) has been stable over the past year.
About the Company
TaiDoc Technology Corporation manufactures and markets medical devices worldwide. It offers In vitro diagnostics products, including blood glucose and multiple parameters monitoring systems, point of care testing devices, lancet and lancing devices, and vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, thermometers, blood pressure monitors, vital sign monitors, and pulse oximeters. The company also provides telehealth remote monitoring devices and smartphone applications; and Covid-19 antigen rapid test kits.
TaiDoc Technology Fundamentals Summary
|4736 fundamental statistics|
Is 4736 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4736 income statement (TTM)|
|Cost of Revenue||NT$3.75b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||32.69|
|Net Profit Margin||34.37%|
How did 4736 perform over the long term?See historical performance and comparison
9.3%Current Dividend Yield
Is 4736 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4736?
Other financial metrics that can be useful for relative valuation.
|What is 4736's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 4736's PE Ratio compare to its peers?
|4736 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
6762 Delta Asia International
4163 INTAI Technology
4116 BenQ Medical Technology
4736 TaiDoc Technology
Price-To-Earnings vs Peers: 4736 is good value based on its Price-To-Earnings Ratio (4.9x) compared to the peer average (30.2x).
Price to Earnings Ratio vs Industry
How does 4736's PE Ratio compare vs other companies in the TW Medical Equipment Industry?
Price-To-Earnings vs Industry: 4736 is good value based on its Price-To-Earnings Ratio (4.9x) compared to the TW Medical Equipment industry average (18.9x)
Price to Earnings Ratio vs Fair Ratio
What is 4736's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||4.9x|
|Fair PE Ratio||6.4x|
Price-To-Earnings vs Fair Ratio: 4736 is good value based on its Price-To-Earnings Ratio (4.9x) compared to the estimated Fair Price-To-Earnings Ratio (6.4x).
Share Price vs Fair Value
What is the Fair Price of 4736 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4736 (NT$161) is trading below our estimate of fair value (NT$206.22)
Significantly Below Fair Value: 4736 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is TaiDoc Technology forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4736's earnings are forecast to decline over the next 3 years (-35.8% per year).
Earnings vs Market: 4736's earnings are forecast to decline over the next 3 years (-35.8% per year).
High Growth Earnings: 4736's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 4736's revenue is expected to decline over the next 3 years (-16.5% per year).
High Growth Revenue: 4736's revenue is forecast to decline over the next 3 years (-16.5% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4736's Return on Equity is forecast to be low in 3 years time (15.6%).
Discover growth companies
How has TaiDoc Technology performed over the past 5 years?
Past Performance Score6/6
Past Performance Score 6/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4736 has high quality earnings.
Growing Profit Margin: 4736's current net profit margins (34.4%) are higher than last year (29.5%).
Past Earnings Growth Analysis
Earnings Trend: 4736's earnings have grown significantly by 36.4% per year over the past 5 years.
Accelerating Growth: 4736's earnings growth over the past year (74.8%) exceeds its 5-year average (36.4% per year).
Earnings vs Industry: 4736 earnings growth over the past year (74.8%) exceeded the Medical Equipment industry 19%.
Return on Equity
High ROE: 4736's Return on Equity (37.1%) is considered high.
Discover strong past performing companies
How is TaiDoc Technology's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 4736's short term assets (NT$9.2B) exceed its short term liabilities (NT$5.1B).
Long Term Liabilities: 4736's short term assets (NT$9.2B) exceed its long term liabilities (NT$403.1M).
Debt to Equity History and Analysis
Debt Level: 4736 has more cash than its total debt.
Reducing Debt: 4736's debt to equity ratio has reduced from 74.6% to 13.8% over the past 5 years.
Debt Coverage: 4736's debt is well covered by operating cash flow (238.1%).
Interest Coverage: 4736's interest payments on its debt are well covered by EBIT (1499.8x coverage).
Discover healthy companies
What is TaiDoc Technology current dividend yield, its reliability and sustainability?
Dividend Score 5/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|TaiDoc Technology Dividend Yield vs Market|
|Company (TaiDoc Technology)||9.3%|
|Market Bottom 25% (TW)||2.6%|
|Market Top 25% (TW)||7.0%|
|Industry Average (Medical Equipment)||3.9%|
|Analyst forecast in 3 Years (TaiDoc Technology)||9.1%|
Notable Dividend: 4736's dividend (9.28%) is higher than the bottom 25% of dividend payers in the TW market (2.59%).
High Dividend: 4736's dividend (9.28%) is in the top 25% of dividend payers in the TW market (7%)
Stability and Growth of Payments
Stable Dividend: 4736's dividend payments have been volatile in the past 10 years.
Growing Dividend: 4736's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (45.5%), 4736's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (60.4%), 4736's dividend payments are covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
TaiDoc Technology has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
TaiDoc Technology Corporation's employee growth, exchange listings and data sources
- Name: TaiDoc Technology Corporation
- Ticker: 4736
- Exchange: TPEX
- Founded: 1998
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: NT$15.044b
- Shares outstanding: 93.44m
- Website: https://www.taidoc.com
- TaiDoc Technology Corporation
- No. 127, Wugong 2nd Road
- B1-7th Floor
- New Taipei City
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|4736||TPEX (Taipei Exchange)||Yes||Common Stock||TW||TWD||Sep 2008|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/03 00:00|
|End of Day Share Price||2022/10/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.